ASK Company Harvard Araliadiol Research

EITC, the parent company of RIMAN, has entered into a sponsored research agreement with the Mitragotri Laboratory at Harvard University's John A. Paulson School of Engineering and Applied Sciences. The collaboration, formalized on April 13, 2026, aims to validate the functionality and effectiveness of Araliadiol, a proprietary ingredient derived from RIMAN's signature Giant BYoungPool. Araliadiol has shown multiple biological benefits, including anti-inflammatory and antioxidant effects. This research will leverage organ-on-a-chip technology to evaluate Araliadiol's potential for skin regeneration and hair growth. Previously, EITC collaborated with Sungkyunkwan University and Konkuk University to understand Araliadiol's mechanism of action and developed a synthetic production process for scalability. Joonghyun Ahn, Founder & Chairman of RIMAN/EITC, and Samir Mitragotri, Professor at Harvard University, attended the agreement ceremony.